Nuclear medicine involves radioactive materials to diagnose and treat diseases. It helps to detect disease at a very early stage. Nuclear medicine helps to treat several diseases such as cancer, heart disease, neurological disorders, and gastrointestinal diseases among others. Nuclear medicine helps to detect medical conditions that are rare and may require invasive diagnostic tests or surgery to chart a line of treatment.
Majorly fuelling the nuclear medicine market is rising incidence of different diseases and exponential growth of the healthcare industry to serve the demand for accurate and efficient medical scans. The rising incidence of cardiovascular diseases and cancer, which in turn has fuelled the demand for positron emission tomography and photon emission computed tomography (SPECT) has been serving to boost the market.
Request Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=4672
On the downside, expensive nature of treatment, regulatory hindrances, and inadequate stock of substances for nuclear medicine are bottlenecks to the market’s growth. Nonetheless, practices of business alliances and partnerships among market players and increasing investment for research and development of nuclear medicine are likely to open myriad opportunities for the market’s growth.